Quick Answer
HOOKIPA Pharma Inc. reported Total Revenue of $43.95 million for the year ending 2024.
- HOOKIPA Pharma Inc. showed an increase of +118.3% in Total Revenue from 2023 to 2024.
- This data is from HOOKIPA Pharma Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $649.0 thousand | Q3 2018: $1.90 million | Q4 2018: $5.08 million | Q1 2019: $2.24 million | Q2 2019: $4.05 million | Q3 2019: $2.04 million | Q4 2019: $3.62 million | Q1 2020: $3.70 million | Q2 2020: $6.69 million | Q3 2020: $4.04 million | Q4 2020: $5.16 million | Q1 2021: $5.30 million | Q2 2021: $5.38 million | Q3 2021: $3.87 million | Q1 2022: $1.45 million | Q2 2022: $2.75 million | Q3 2022: $2.23 million | Q1 2023: $3.18 million | Q2 2023: $2.68 million | Q3 2023: $6.87 million | Q1 2024: $36.60 million | Q2 2024: $1.29 million | Q3 2024: $4.70 million | Q1 2025: $2.00 million.
- Over the full 7 years of available data (2018 to 2024), HOOKIPA Pharma Inc.'s Total Revenue has grown by 476.0%.
- Historical annual values: Fiscal year 2024: $43.95 million | Fiscal year 2023: $20.13 million | Fiscal year 2022: $14.25 million | Fiscal year 2021: $18.45 million | Fiscal year 2020: $19.58 million | Fiscal year 2019: $11.94 million | Fiscal year 2018: $7.63 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: